Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rena Emond
Observed name:
Emond, Rena
Institutions:
City Of Hope National Medical Center,
City of Hope,
Beckman Research Institute
Observed institutions:
City Of Hope National Medical Center,
City of Hope,
Beckman Research Institute
ORCID:
0000-0002-4450-0088
Observed ORCID:
0000-0002-4450-0088
OpenAlex ID:
A5009406892
Cell facilitation promotes growth and survival under drug pressure in breast cancer
2023
·
Rena Emond
, Jason I. Griffiths
, et al.
·
Nature Communications
·
30
PDF
Exploiting collateral sensitivity controls growth of mixed culture of sensitive and resistant cells and decreases selection for resistant cells in a cell line model
2020
·
Vince Kornél Grolmusz
, Jinfeng Chen
, et al.
·
Cancer Cell International
·
24
PDF
ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer
2023
·
Elena Farmaki
, Aritro Nath
, et al.
·
eLife
·
16
PDF
A novel combination therapy for ER+ breast cancer suppresses drug resistance via an evolutionary double-bind
2026
·
Rena Emond
, Jeffrey West
, et al.
·
Molecular Systems Biology
·
2
PDF
Abstract 5133: End-stage breast cancer metastases manifest as two subtypes with distinct dissemination patterns, proliferation/EMT signatures, and immune microenvironments
2025
·
Isaac Bishara
, Xuan Liu
, et al.
·
Cancer Research
·
1
Abstract 7353: Exploring intrapatient heterogeneity in metastatic breast cancer: Insights into tumor evolution from a warm procurement trial
2024
·
Isaac Bishara
, Xuan Liu
, et al.
·
Cancer Research
Author response: ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer
2023
·
Elena Farmaki
, Aritro Nath
, et al.
·
eLife
Abstract 388: Acquired sensitivity to ONC201/TIC10 in ER+ breast cancer progressing on the mTOR inhibitor everolimus
2023
·
Eleni Farmaki
, Rena Emond
, et al.
·
Cancer Research
Abstract 3164: Disulfiram re-sensitizes ER+ breast cancer cells resistant to chemotherapy through an evolutionary double-bind
2023
·
Rena Emond
, Jeffrey West
, et al.
·
Cancer Research
Abstract 1005: Ecological interactions in breast cancer: Cell cooperation within heterogeneous populations promotes growth and survival under drug pressure
2022
·
Rena Emond
, Jason Griffiths
, et al.
·
Cancer Research
Abstract P4-01-18: Acquired sensitivity strategies in ER+ breast cancer progressing on CDK4/6 and mTOR inhibitors
2022
·
Eleni Farmaki
, Rena Emond
, et al.
·
Cancer Research
Abstract 3133: Clonal facilitation drives estrogen receptor positive (ER+) breast cancer growth and survival
2021
·
Rena Emond
, Vince K. Grolmusz
, et al.
·
Cancer Research
Show more works
View as search
Works count:
16
Citation count:
73
H-index:
3
I10-index:
3
Year
Topic
Type